FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industires Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Risedronate Sodium submitted by Sun Pharmaceutical Industries Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

SUPPL AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)